Syed Rizvi, M.D.

Syed Rizvi, M.D.

  • Internal Medicine - Hematology/Oncology
  • General Hematology/Oncology
  • Lymphoma Treatment

Biography

Syed M. Rizvi, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center.

Certified by both the American Board of Internal Medicine and the American Board of Hematology, he is a hematologist-oncologist who specializes in malignant hematology – particularly in evaluating and treating patients with lymphoma.

Dr. Rizvi’s research interests include hematological malignancies, peripheral and cutaneous T-cell lymphomas, geriatric oncology, and transplant medicine.

He joined the UT Southwestern faculty in 2016.

Dr. Rizvi earned his medical degree at Aga Khan University Medical College in Pakistan. He completed an internal medicine residency and a hematology-oncology fellowship at Penn State Milton S. Hershey Medical Center and a geriatric medicine fellowship at Miami’s Jackson Health System.

Dr. Rizvi has been a member of the American College of Physicians, American Society of Clinical Oncology, American Society of Hematology, and Society of General Internal Medicine.

See More

Meet Dr. Rizvi

Lymphoma Specialist in Dallas

Hematologist-oncologist Syed Rizvi, M.D., specializes in evaluating and treating lymphoma (cancer of the lymphatic system) at UT Southwestern Medical Center.

“Cancers are smart diseases, and you have to outsmart them to get the upper hand,” he says.

“My patients and I end up becoming like family. We're in it together.”

Dr. Rizvi works to get the upper hand for patients with all types of hematological malignancies, including Hodgkin lymphoma, low- and high-grade non-Hodgkin lymphoma, and cutaneous (skin) lymphoma.

He also has special expertise in caring for seniors with lymphoma.

“I think my background in geriatrics gives me a unique lens through which I'm able to look at older people in totality, rather than seeing them simply as seniors with cancer,” he says.

“We’re now looking more at older patients’ functional ages rather than their chronological ages and using more objective tools to assess things such as frailty, and both of those factors help us manage their care more effectively.”

Following the Golden Rule

Fellowship trained and board certified in both internal medicine and hematology, Dr. Rizvi believes in adhering to The Golden Rule when it comes to patient care.

“I treat my patients the way I’d want myself or my family members to be treated – that’s number one,” he says. “A cancer diagnosis can be earth-shattering, and our team is here to help guide patients through the treatments and related services.”

He believes that patient education and personalized care are important parts of that help.

“I try to have a detailed conversation with every patient – up front, in lay language – so they understand their illness, their treatment options, and what the treatment process entails over time,” he says.

“And because each patient is unique, we strive to provide individualized care that is based on sound scientific principles as well as tailored to each patient’s needs.”

Dr. Rizvi says he enjoys caring for his patients and grows close to many of them.

“I think we’re able to make a difference in our patients’ lives, and that’s very fulfilling,” he says.

“As we work with and help these people during a difficult time in their lives, a relationship develops, and I want to be there for them when they need me.”

See More

Education & Training
  • Fellowship - Penn State Milton S. Hershey Medical Center (2012-2015), Hematology Oncology
  • Fellowship - Jackson Memorial Hospital (2011-2012), Geriatric Medicine
  • Residency - Penn State Milton S. Hershey Medical Center (2008-2011), Internal Medicine
  • Medical School - Aga Khan University Medical College, Pakistan (2000-2005)
Research
  • Transplant Medicine
  • Peripheral T-cell Lymphoma
  • Hematological Malignancies
  • Geriatric Oncology
  • Cutaneous T-cell Lymphoma

Clinical Focus

  • General Hematology/Oncology
  • Lymphoma Treatment

See More